AAIC and Ohara Pharmaceutical’s investment in Revital Healthcare’s operations in Kenya

Lead party: Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd. (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Revital Healthcare (EPZ) Limited (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Kenya Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument:…


Lead party: Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd. (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Revital Healthcare (EPZ) Limited (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Kenya

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: Africa Healthcare Fund I (AHF1)

Lead investor/buyer: Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd. · Investors/buyers: Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd.

Legal advisers: not identified in the source record.

Source: announced 27 December 2021. Original announcement: aa-ic.com.